language_icon
EN
HI

JB Chemicals & Pharmaceuticals Share price

JBCHEPHARM

2011.5

33.70 (1.70%)
NSE
BSE
Last updated on 23 Apr, 2026 | 15:50 IST
Today's High

2033.70

Today's Low

1960.20

52 Week Low

1494.80

52 Week High

2195.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

JB Chemicals & Pharmaceuticals Chart

JB Chemicals & Pharmaceuticals Share Key Metrics

Volume
3.55 L
Market Cap
32296.38 CR
LTQ@LTP
1@2011.50
ATP
2014.94
Var Margin
13.34 %
Circuit Range
1582.3-2373.3
Delivery %
67.44 %
Value
71.46 CR
ASM/GSM
No
Market Lot
1

Summary

23 Apr, 2026 | 15:50 को, JB Chemicals & Pharmaceuticals का शेयर प्राइस आज ₹2011.5 पर है, जो दिन के लिए 33.70% की 1.70 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1960.20 और ₹2033.70 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1494.80 से ₹2195.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, JB Chemicals & Pharmaceuticals ने 354656 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹160558706 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹201494 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,201150 रही। यह स्टॉक ₹1582.3-2373.3 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹71.46 CR है। दिन के लिए डिलीवरी परसेंटेज 67.44% रही। इसके अतिरिक्त, JB Chemicals & Pharmaceuticals वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

JB Chemicals & Pharmaceuticals Fundamentals

View More
P/E Ratio

42.05

P/B Ratio

7.92

Div. Yield

0.79

Sector P/E

64.34

Sector P/B

3.51

Sec. Div. Yield

0.57

JB Chemicals & Pharmaceuticals Resistance and Support

Pivot 1982.13

Resistance

First Resistance

1995.56

Second Resistance

2013.33

Third Resistance

2026.76

Support

First Support

1964.36

Second Support

1950.93

Third Support

1933.16

JB Chemicals & Pharmaceuticals Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

48.8%

Mutual Fund

19%

Insurance

1.33%

Foreign Institutional Investors

16.33%

Domestic Institutional Investors

1.05%

Retail

13.48%

Others

0.01%

Total Promoters
MAR '26
48.8%

JB Chemicals & Pharmaceuticals Corporate Actions

DateAgenda
2026-02-05Interim Dividend
2026-01-16Quarterly Results

JB Chemicals & Pharmaceuticals News

JB Chemicals & Pharmaceuticals Ltd - 506943 - Announcement under Regulation 30 (LODR)-Cessation

Mr. Nikhil Chopra has ceased to be the Chief Executive Officer and Key Managerial Personnel of JB Chemicals & Pharmaceuticals with effect from the closing of business hours of March 31, 2026. This resignation is due to personal reasons and to pursue other professional opportunities.
Apr 01 2026 13:04:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

J.B. Chemicals & Pharmaceuticals Limited announced that the National Company Law Tribunal (NCLT) has issued a Corrigendum Order related to its proposed amalgamation with Torrent Pharmaceuticals Limited. This update follows an earlier intimation regarding the scheme.
Mar 25 2026 19:03:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

NCLT Ahmedabad Bench has uploaded the order on March 23, 2026, for J.B. Chemicals & Pharmaceuticals' amalgamation with Torrent Pharmaceuticals Limited. This marks a significant procedural step towards completing the scheme of amalgamation.
Mar 24 2026 19:03:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Appointment Of Directors

J. B. Chemicals & Pharmaceuticals shareholders have approved key appointments to its Board. Mr. Aman Mehta has been appointed as Director and Managing Director, effective January 21, 2026, for three years. Additionally, Mr. Amal Kelshikar, Mr. Hasmukh Patel, and Mr. Sudhir Menon have been appointed as Non-Executive Non-Independent Directors, effective March 23, 2026.
Mar 24 2026 19:03:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

JB Chemicals shareholders approved all five postal ballot resolutions, including the appointment of Aman Mehta as Managing Director and four Non-Executive Non-Independent Directors. All resolutions passed with over 99% votes in favour during the e-voting period from February 22 to March 23, 2026.
Mar 24 2026 19:03:00

JB Chemicals & Pharmaceuticals Ltd - 506943 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

JB Chemicals shareholders approved all five postal ballot resolutions, including the appointment of Aman Mehta as Managing Director and four Non-Executive Non-Independent Directors. All resolutions passed with over 99% votes in favour during the e-voting period from February 22 to March 23, 2026.
Mar 24 2026 19:03:00
Read More

About JB Chemicals & Pharmaceuticals AboutThe

NSE : 1726  
BSE : 506943  
ISIN : INE572A01036  

The Company was incorporated in December 1976 in the nameof J.B. Mody Chemicals and Pharmaceuticals Ltd. Later thename was changed to J.B. Chemical and Pharmaceuticals Ltd.and a fresh Certificate of Incorporation upon change ofname was issued on 21/08/85 by the Registrar of CompaniesMaharashtra at Mumbai.J.B. Chemicals and Pharmaceuticals Ltd. is the flagship ofthe ''Unique'' group of companies. The Company was foundedby Mr. J.B. Mody along with his two brothers Mr. D.B.Mody and Mr. S.B. Mody. It is engaged in the business ofmanufacturing bulk drugs intermediates formulationsayurvedic and herbal preparations. The Company''smanufacturing facilities are situated at Thane BelapurAnkleshwar Panoli and Daman. The product rangemanufactured at each of the plants is given below:------------------------------------------------------------Plant Year in which Products manufacturedSite set up / acquired------------------------------------------------------------Thane 1985 formulationsBelapur 1985 bulk drugs and intermediates.Ankleshwar 1985 bulk drugs intermediates formulations based on metroni- dazole and diclofenac sodium.Panoli 1992 soft gelatine capsules. 1994 liquid formulations. 1995 bulk drug plant to manufacture diclofenac sodium and intermediates.Daman 1995 cardiovascular formulations mainly in the form of tables and capsules and ayurvedic preparations.------------------------------------------------------------JBCPLs multi-locational multi-products plants enable it tocater to a large portion of the market. Today the Companyhas 46 products catering to 11 therapeutic segments. It isranked 37th in terms of domestic retail sales amongst thepharmaceutical companies in India (Source : ORG).

Read More

JB Chemicals & Pharmaceuticals Management

NamePosition
Sandeep PhadnisVice President- Secretarial & Company Secretary & Compliance Officer
Arun DuggalChairman
View More

JB Chemicals & Pharmaceuticals FAQs

JB Chemicals & Pharmaceuticals शेयर का खरीद मूल्य 2011.5 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

JB Chemicals & Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

JB Chemicals & Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 42.05 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

JB Chemicals & Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 7.92 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

JB Chemicals & Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.51 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

JB Chemicals & Pharmaceuticals का मार्केट कैप 32296.38 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

JB Chemicals & Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2195.00 और 1494.80 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost